Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Ho Tony W, Vice-Président Exécutif, Responsable de la R&D. Officer active across 1 company, notably CRISPR Therapeutics AG. Cumulatively, 1 filings have been recorded. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Ho Tony W is the Executive VP, Head of R&D at CRISPR Therapeutics AG. He oversees the company's research and development initiatives, ensuring innovation and advancement of scientific projects. Tony brings in-depth expertise in the biotechnology field, contributing to the evolution of gene therapies.